A Response to: Letter to the Editor Regarding 'Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age'

被引：1
|
作者：
Rozenbaum, Mark H. [1 ]
Perdrizet, Johnna [2 ]
Li, Xiuyan [2 ]
Wasserman, Matt D. [3 ]
Grant, Lindsay R. [4 ]
Hayford, Kyla [4 ]
Farkouh, Raymond A. [1 ]
机构：
[1] Pfizer, Hlth Econom & Outcomes Res, Capelle Aan Den Ijssel, Netherlands
[2] Pfizer Inc, Hlth Econom & Outcomes Res, New York, NY USA
[3] Pfizer Inc, Patient & Hlth Impact, New York, NY USA
[4] Pfizer Inc, Vaccines Med Dev & Sci & Clin Affairs, New York, NY USA
来源：
INFECTIOUS DISEASES AND THERAPY | 2023年 / 12卷 / 01期
关键词：
COST-EFFECTIVENESS; VACCINATION;
D O I：
10.1007/s40121-022-00719-4
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：295 / 298
页数：4
相关论文
共 40 条
  • [31] Impact of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children under 15 years old in Madrid, Spain, 2007 to 2016: The HERACLES clinical surveillance study
    Picazo, Juan J.
    Ruiz-Contreras, Jesus
    Casado-Flores, Juan
    Negreira, Sagrario
    Baquero-Artigao, Fernando
    Hernandez-Sampelayo, Teresa
    Otheo, Enrique
    del Amo, Maria
    Mendez, Cristina
    Ramos, J. T.
    Betriu, C.
    Culebras, E.
    Gonzalez, F.
    Rodriguez-Avial, I
    Ruiz-Contreras, J.
    Negreira, S.
    Orellana, M. A.
    Delgado-Iribarren, A.
    Bueno, M.
    Alhambra, A.
    Garcia, M. T.
    Gonzalez, M. J.
    Cobos, J.
    Baquero, F.
    Garcia, A.
    Casado, J.
    Hernandez, B.
    Zafra, M.
    Jaqueti, J.
    Calvo, C.
    Wilhelmi, I
    Serrano, C.
    Garcia-Penuela, E.
    Cercenado, E.
    Hernandez-Sampelayo, T.
    Otheo, E.
    Ruiz, P.
    Dominguez, N.
    Gadea, I
    Romero, I
    Gomez-Garces, J. L.
    Roa, M. A.
    Ruiz, M.
    Cacho, J.
    Garcia-Picazo, M. L.
    Gallego, S.
    Cilleruelo, M. J.
    Sanchez, M., I
    Penin, M.
    Gomez, P.
    VACCINE, 2019, 37 (16) : 2200 - 2207
  • [32] Decrease in Hospitalizations for Pneumonia in Children under Five Years of Age in an Indian Reservation in Panama after the Introduction of the Heptavalent Pneumococcal Conjugate Vaccine (PCV7)
    Guevara, Javier Nieto
    Daza, Carlos
    Smith, Rebecca
    INTERNATIONAL JOURNAL OF PEDIATRICS, 2013, 2013
  • [33] Impact of the introduction of pneumococcal conjugate vaccine on the epidemiology of invasive disease in children less than five years of age within Northern California Kaiser Permanente (NCKP)
    Shinefield, H
    Black, S
    Elvin, L
    Ray, P
    Lewis, E
    Fireman, B
    Malinoski, F
    Laufer, D
    Austrian, R
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1093 - 1093
  • [34] Emerging of non-vaccine Streptococcus pneumoniae serotypes colonizing the nasopharynx of children under the age of five years in the 13-vallent pneumococcal conjugate vaccine era in Moshi district, Tanzania. A short communication
    Ngocho, James Samwel
    de Jongh, Christa E. van der Gaast
    Sebba, Julieth
    Mtei, Monica
    Kinabo, Grace
    Mmbaga, Blandina T.
    de Jonge, Marien
    VACCINE, 2025, 48
  • [35] Risk factors for community-acquired pneumonia in children under five years of age in the post-pneumococcal conjugate vaccine era in Brazil: a case control study
    da Fonseca Lima, Eduardo Jorge
    Goncalves Mello, Maria Julia
    Pessoa Militao de Albuquerque, Maria de Fatima
    Londres Lopes, Maria Isabella
    Cordeiro Serra, George Henrique
    Pessoa Lima, Debora Ellen
    Correia, Jailson Barros
    BMC PEDIATRICS, 2016, 16
  • [36] Risk factors for community-acquired pneumonia in children under five years of age in the post-pneumococcal conjugate vaccine era in Brazil: a case control study
    Eduardo Jorge da Fonseca Lima
    Maria Júlia Gonçalves Mello
    Maria de Fátima Pessoa Militão de Albuquerque
    Maria Isabella Londres Lopes
    George Henrique Cordeiro Serra
    Debora Ellen Pessoa Lima
    Jailson Barros Correia
    BMC Pediatrics, 16
  • [37] Acute mastoiditis in children under 15 years of age in Southern Israel following the introduction of pneumococcal conjugate vaccines: A 4-year retrospective study (2009-2012)
    Kordeluk, Sofia
    Orgad, Ran
    Kraus, Mordechai
    Puterman, Moshe
    Kaplan, Daniel M.
    Novak, Lena
    Dagan, Ron
    Leibovitz, Eugene
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2014, 78 (10) : 1599 - 1604
  • [38] Changes in serotypes causing invasive pneumococcal disease (2005-2007 vs. 1997-1999) in children under 2 years of age in a population with intermediate coverage of the 7-valent pneumococcal conjugated vaccine
    Salleras, L.
    Dominguez, A.
    Ciruela, P.
    Izquierdo, C.
    Navas, E.
    Torner, N.
    Borras, E.
    CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 (11) : 997 - 1001
  • [39] The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area
    Deshpande, SA
    Northern, V
    ARCHIVES OF DISEASE IN CHILDHOOD, 2003, 88 (12) : 1065 - 1069
  • [40] Epidemiology of invasive bacterial infections in pneumococcal conjugate vaccine-vaccinated and -unvaccinated children under 5 years of age in Soweto, South Africa: a cohort study from a high-HIV burden setting
    Johnstone, Siobhan L.
    Moore, David P.
    Klugman, Keith P.
    Madhi, Shabir A.
    Groome, Michelle J.
    PAEDIATRICS AND INTERNATIONAL CHILD HEALTH, 2020, 40 (01) : 50 - 57
1234